LPL Financial LLC Acquires 3,325 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

LPL Financial LLC grew its holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 3.5% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 98,751 shares of the company’s stock after purchasing an additional 3,325 shares during the period. LPL Financial LLC owned approximately 1.72% of SPDR S&P Pharmaceuticals ETF worth $4,048,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of XPH. Money Concepts Capital Corp bought a new stake in SPDR S&P Pharmaceuticals ETF during the 4th quarter worth $54,000. Captrust Financial Advisors grew its position in SPDR S&P Pharmaceuticals ETF by 23.2% during the 1st quarter. Captrust Financial Advisors now owns 1,388 shares of the company’s stock worth $63,000 after acquiring an additional 261 shares during the last quarter. Rockefeller Capital Management L.P. bought a new stake in SPDR S&P Pharmaceuticals ETF during the 4th quarter worth $123,000. BNP Paribas Arbitrage SNC grew its position in SPDR S&P Pharmaceuticals ETF by 10.0% during the 3rd quarter. BNP Paribas Arbitrage SNC now owns 3,861 shares of the company’s stock worth $155,000 after acquiring an additional 352 shares during the last quarter. Finally, BNP Paribas Arbitrage SA grew its position in SPDR S&P Pharmaceuticals ETF by 17.5% during the 1st quarter. BNP Paribas Arbitrage SA now owns 4,375 shares of the company’s stock worth $198,000 after acquiring an additional 651 shares during the last quarter.

SPDR S&P Pharmaceuticals ETF Trading Up 2.4 %

NYSEARCA XPH opened at $37.33 on Monday. The business’s 50-day moving average price is $39.87 and its two-hundred day moving average price is $41.06. SPDR S&P Pharmaceuticals ETF has a 12 month low of $35.27 and a 12 month high of $44.31. The firm has a market capitalization of $195.98 million, a PE ratio of 10.11 and a beta of 0.84.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.